Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

Our fashion team has been hunting Black Friday fashion deals for years – here are the 24 items we really rate

Plenty of brands have already dropped major Black Friday discounts, and these are items worth shopping right now

Woman & Home

Exact Sciences Stock Pops on $21 Billion Deal. Is It Too Late to Buy EXAS Here?

Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.

Barchart

Abbott-Exact Sciences Deal Set to Shake Up Diagnostic Market with Cancer-Fighting Acquisition

Rumours fly that Abbott is very close to sealing the deal to acquire cancer treatment champion Exact Sciences.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics

Abbott Laboratories (NYSE:ABT) agreed on Thursday to acquire cancer screening company Exact Sciences Corp (NASDAQ:EXAS) for $105 per common share, representing a total equity value of approximately $21 billion and an estimated enterprise value of $23 billion.

Benzinga

The Paper Is A Blast, And I Want A Specific Crossover With Abbott Elementary

Hear me out.

Cinemablend

The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep?

Stocks dropped hard last week, but a late-day rally on Friday staved off the worst. The Dow Jones Industrial Average held up the best, only closing down 1.21%. The SP 500 was down 1.63%, but the Nasdaq suffered the most, as it closed down 3.04%. Tech was routed hard as…

Benzinga

Preliminary tests find germ that causes botulism in ByHeart baby formula

California health officials say tests showed that ByHeart baby formula linked to a botulism outbreak contained the type of bacteria that produces the toxin that has sickened at least 13 infants in 10 states

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Abbott Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Despite underperforming the broader market over the past year, Wall Street analysts remain highly bullish on Abbott Laboratories' long-term outlook.

Barchart

5 Dividend Aristocrats Proving That Reliability Still Pays in 2025

These five companies offer stability in terms of growth and income.

Barchart

Abbott Laboratories' October Price Plunge Is a Signal to Buy

Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend.

MarketBeat

Analyst Sees Noise In Q3 P&L, Affirms Abbott's Medtech Strength

Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance.

Benzinga

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter and narrowed fiscal 2025 guidance on Wednesday.

Benzinga

Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations

Abbott Laboratories (NYSE:ABT) stock fell after the company reported muted sales in the third quarter and narrowed fiscal 2025 guidance.

Benzinga

Abbott Elementary's Season 5 Premiere Had A Lot Of Moving And Shaking, And I Need To Talk About One Specific Change

Well, this will be fun!

Cinemablend

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What to Expect From Abbott Laboratories' Next Quarterly Earnings Report

Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Benzinga

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Barchart

3 Dividend Kings That Pay - and Beat the Market Too

These Dividend Kings are outperforming the S&P 500 in 2025 while extending decades of payout growth and earning strong buy ratings.

Cinemablend

Quinta Brunson Said Abbott Elementary's Season 5 Christmas Episode Will Be 'A Game Changer,' And I Have A Few Wild Guesses About Why

Hear me out...

Get all your
news in one place.

100's of premium titles.
One news app.

Cinemablend

Why Abbott Elementary Doesn’t Want To Go ‘The Easy Route’ With Janine And Gregory’s Relationship In Season 5

Janine and Gregory fans can celebrate!

Barchart

Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Sports Illustrated

‘A Goal of Ours’—U.S. Soccer Standouts Talk Growth of Game Ahead of PL Summer Series

Tyler Adams and Tim Howard spoke to Sports Illustrated about the growth of soccer in the U.S.

Barchart

3 Dividend Stocks With 100+ Years of History and Sky-High Growth

These three century-old companies boast strong buy ratings, 50%+ dividend growth, and rock-solid fundamentals—ideal picks for long-term income investors.

MarketBeat

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield

Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.

Benzinga

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.

Benzinga

Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors

Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.